Microglia Activated with the Toll-Like Receptor 9 Ligand CpG Attenuate Oligomeric Amyloid β Neurotoxicity in in Vitro and in Vivo Models of Alzheimer’s Disease

Doi, Yukiko, Mizuno, Tetsuya, Maki, Yuki, Jin, Shijie, Mizoguchi, Hiroyuki, Ikeyama, Masayoshi, Doi, Minoru, Michikawa, Makoto +2 more·2009·The American Journal of Pathology

Cited by (135)

Items 101–135 of 135

  1. Adeno-associated virus (AAV) reduces cortical dendritic complexity in a TLR9-dependent manner
    Christos Michael Suriano, Jessica L. Verpeut, Neerav Kumar, Jie Ma, Caroline Jung, Lisa M. Boulanger · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Innate immune responses after stimulation with Toll-like receptor agonists in ex vivo microglial cultures and an in vivo model using mice with reduced microglia
    James A. Carroll, Brent Race, Katie Williams, James F. Striebel, Bruce W. Chesebro · 2021 · Journal of Neuroinflammation
  3. Recent Developments in Targeting Neuroinflammation in Disease
    Allen T. Hopper, Brian M. Campbell, Henry W. Kao, Sean A. Pintchovski, Roland G. W. Staal · 2012 · Annual reports in medicinal chemistry
  4. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches
    Younes Yassaghi, Yasaman Nazerian, Mobina Ghasemi, Amirhossein Nazerian, Fatemeh Sayehmiri, George L. Perry, Hamid Gholami Pourbadie · 2024 · Journal of Cellular and Molecular Medicine
  5. Activation of the MAC1-ERK1/2-NOX2 Pathway Is Required for LPS-Induced Sustaining Reactive Microgliosis, Chronic Neuroinflammation and Neurodegeneration
    Shih‐Heng Chen, Shuangyu Han, Chih-Fen Hu, Ran Zhou, Yun Gao, Dezhen Tu, Hui‐Ming Gao, Jing Feng, Yubao Wang, Ru‐Band Lu et al. · 2022 · Antioxidants
  6. Long-Term High-Fat Diet Consumption Depletes Glial Cells and Tyrosine Hydroxylase–Containing Neurons in the Brain of Middle-Aged Rats
    Mei‐Chuan Chou, Hsiang‐Chun Lee, Yen‐Chin Liu, Patrick Szu-Ying Yen, Ching‐Kuan Liu, Chu‐Huang Chen, Tzu-Han Hsieh, Shiou‐Lan Chen · 2022 · Cells
  7. Spongiform degeneration induced by neuropathogenic murine coronavirus infection
    Hiromi Kashiwazaki, Risa Nomura, Shutoku Matsuyama, Fumihiro Taguchi, Rihito Watanabe · 2011 · Pathology International
  8. Embryonic Neocortical Microglia Express Toll-Like Receptor 9 and Respond to Plasmid DNA Injected into the Ventricle: Technical Considerations Regarding Microglial Distribution in Electroporated Brain Walls
    Yuki Hattori, Takaki Miyata · 2018 · eNeuro
  9. Granulocyte-Colony Stimulating Factor Attenuates Oligomeric Amyloid β Neurotoxicity by Activation of Neprilysin
    Yukiko Doi, Hideyuki Takeuchi, Hiroyuki Mizoguchi, Kazuya Fukumoto, Hiroshi Horiuchi, Shijie Jin, Jun Kawanokuchi, Bijay Parajuli, Yoshifumi Sonobe, Tetsuya Mizuno et al. · 2014 · PLoS ONE
  10. Roles of Microglia in AD Pathology
    Rong Gao, Hongrong Wu, Qingqi Li, Jianfeng Zhao · 2023 · Current Alzheimer Research
  11. Microglia in neurodegenerative disorders and neuroinflammation
    Akio Suzumura · 2014 · Rinsho Shinkeigaku
  12. Insulin Mediates Lipopolysaccharide-Induced Inflammatory Responses and Oxidative Stress in BV2 Microglia
    Chi-Chen Huang, Sheng‐Feng Tsai, Shucheng Liu, Mei-Chen Yeh, Hao‐Chang Hung, Chu-Wan Lee, Ching‐Li Cheng, Pei‐Ling Hsu, Yu-Min Kuo · 2024 · Journal of Inflammation Research
  13. Roles of Toll-Like Receptors in Pathophysiology of Alzheimer’s Disease and Multiple Sclerosis
    Shyamal C. Bir, Oleg Y. Chernyshev, Alireza Minagar · 2018 · Elsevier eBooks
  14. Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
    Tarja Malm, Johanna M. Magga, Jari Koıstınaho · 2012 · Current Translational Geriatrics and Experimental Gerontology Reports
  15. Toll-Like Receptor Signaling in Alzheimer?s Disease Progression
    Eric J. Downer · 2012 · Journal of Alzheimer’s Disease & Parkinsonism
  16. Oligomeric amyloid β facilitates microglial excitotoxicity by upregulating tumor necrosis factor‐α and downregulating excitatory amino acid transporter 2 in astrocytes
    Hiroshi Horiuchi, Bijay Parajuli, Jun Kawanokuchi, Shijie Jin, Tetsuya Mizuno, Hideyuki Takeuchi, Akio Suzumura · 2015 · Clinical and Experimental Neuroimmunology
  17. Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies
    Shubham Upadhayay · 2026 · International Immunopharmacology
  18. Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?
    María Clara Sellés, Juliana T.S. Fortuna, Luís E. Santos · 2017 · Journal of Neuroscience
  19. Capturing Amyloid-β Oligomers by Stirring with Microscaled Iron Oxide Stir Bars into Magnetic Plaques to Reduce Cytotoxicity toward Neuronal Cells
    Yuan-Chung Tsai, Jing-Chian Luo, Te‐I Liu, I-Lin Lu, Ming‐Yin Shen, Chun‐Yu Chuang, Chorng‐Shyan Chern, Hsin‐Cheng Chiu · 2020 · Nanomaterials
  20. Toll‑Like receptor 4 promotes the phosphorylation of CRMP2 via the activation of Rho‑kinase in MCAO rats
    Xue‐Bo Li, Ming‐Xia Ding, Chun-Li Ding, Liang‐Liang Li, Jinzhou Feng, Xiaojun Yu · 2018 · Molecular Medicine Reports
  21. Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits
    Henrieta Scholtzova, Eileen Do, Shleshma Dhakal, Yanjie Sun, Shan Liu, Pankaj D Mehta, Thomas Wısnıewskı · 2017 · Journal of Neuroscience
  22. Innate Immune Mechanisms in the Central Nervous System
    Abhishek Shastri, Hadida Yasmin, Uday Kishore · 2025 · Advances in experimental medicine and biology
  23. Central Role of Toll-like Receptor-9 Gene Function in Inflammation-Mediated Neuronal Plasticity: Implications for Long-Term Memory Development
    Mega Obukohwo Oyovwi, Victor Oghenekparobo Emojevwe, Benneth Ben‐Azu, Ejayeta Jeroh · 2025 · Molecular Neurobiology
  24. Alzheimer’s disease vaccines: promises and pitfalls
    Takeshi Tabira · 2011 · Clinical Investigation
  25. Acute, Chronic, and Nonclassical Neuroinflammation: Definitions in a Changing Scientific Environment
    Robert P. Lisak, Joyce A. Benjamins · 2013 · Advances in neurobiology
  26. Mechanisms and Clinical Significance of Endosomal Toll-Like Receptors in Neurological Diseases
    Weihua Kong, Xinglu Miao, Ruili Dang, Pei Jiang, Lei Feng · 2025 · Molecular Neurobiology
  27. New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
    Deepa S. Mandlik, Satish K. Mandlik, Heena Bholaram Choudhary · 2023 · Current Drug Therapy
  28. The Role of Telomere Maintenance in Adult Mammalian Acute Central Nervous System Injury and Retinal Ganglion Cell Apoptosis
    Meghan D. Lysko · 2016 · TSpace (University of Toronto)
  29. Roles in Immune Responses
    Richa Hanamsagar, Sandra M. Cardona, Tammy Kielian, Astrid E. Cardona · 2014 · Springer eBooks
  30. Erratum to: Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
    Tarja Malm, Johanna M. Magga, Jari Koıstınaho · 2012 · Current Translational Geriatrics and Experimental Gerontology Reports
  31. Neuroinflammation: Microgliosis and astrocytosis in the days of microscopic omics
    Takaomi C. Saido · 2024 · Elsevier eBooks
  32. Role of microglia, mitochondria, and inflammatory events in Alzheimer's disease
    Priti Gupta, Gopenath T.S. · 2024 · Elsevier eBooks
  33. ApoE-directed CpG nano-immunoadjuvant ameliorates Alzheimer's-like pathology in mice
    Xin Huang, Yan-Yun Sun, Yi-Ren Qin, Hong Chen, Ting-Ting Pan, Songsong Zhao, Qian Cai, Xiaoshuo Zhang, Xiao-dong Nie, Lei Feng et al. · 2026 · Journal of Controlled Release
  34. From molecules to behavior : network effects of Alzheimer's disease-associated amyloid beta peptides in a Drosophila melanogaster larval circuit
    Anqi Zhou · 2024 · theses.fr (ABES)
  35. Preclinical gene therapy using recombinant AAV vectors in mouse models of two human diseases
    Yasemin Özgür Günes · 2022 · theses.fr (ABES)